Vital Signs

This week's collection of news and events from the School of Medicine

John Stackhouse, founder of the NC Jaycee Burn Center, passed away

John Stackhouse, founder of the NC Jaycee Burn Center, passed away

Stackhouse pledged $40,000 to help establish the North Carolina Jaycee Burn Center at UNC Hospitals. In addition, he provided a gift to establish the John Stackhouse Distinguished Professorship and lecture series in 1994 and to provide continued support for the Burn Center.

John Stackhouse, founder of the NC Jaycee Burn Center, passed away - Read More…

UNC School of Medicine departments rank high in 2018 NIH funding report

UNC School of Medicine departments rank high in 2018 NIH funding report

All six basic science departments rank in the top 10 in NIH finding, according to a new report by the Blue Ridge Institute for Medical Research, and 11 clinical departments rank in the top 30.

UNC School of Medicine departments rank high in 2018 NIH funding report - Read More…

Dr. Cristy Page Named School of Medicine Executive Dean

Dr. Cristy Page Named School of Medicine Executive Dean

Cristy Page, MD, MPH, Chair of UNC Family Medicine, has been named Executive Dean of the UNC School of Medicine, effective February 18, 2019. This leadership position was vacated when Dr. Wesley Burks assumed the dual role of Dean of the School of Medicine and CEO of UNC Health Care.

Dr. Cristy Page Named School of Medicine Executive Dean - Read More…

Scientists Discover How Neuroactive Steroids Dampen Inflammatory Signaling in Immune System and Brain

Scientists Discover How Neuroactive Steroids Dampen Inflammatory Signaling in Immune System and Brain

Led by Leslie Morrow, PhD, research shows how new compounds could target specific brain cell receptors to treat a wide variety of conditions, such as alcoholism, Alzheimer’s, depression, and posttraumatic stress.

Scientists Discover How Neuroactive Steroids Dampen Inflammatory Signaling in Immune System and Brain - Read More…

‘Virtual Pharmacology’ Advance Tackles Universe of Unknown Drugs

‘Virtual Pharmacology’ Advance Tackles Universe of Unknown Drugs

Pharmacology’s Bryan Roth teamed with UCSF and European researchers to create a platform to screen hundreds of millions of never-before-synthesized compounds and then produce remarkably potent antibacterial and psychiatric drug candidates.

‘Virtual Pharmacology’ Advance Tackles Universe of Unknown Drugs - Read More…

UNC Lineberger awards $1.35M for cancer research

UNC Lineberger awards $1.35M for cancer research

UNC Lineberger awarded grants to 14 scientists and research teams in the fall grant awards cycle. Applications for the next round of funding will be due March 15.

UNC Lineberger awards $1.35M for cancer research - Read More…

UNC-led team awarded $5.1 million for cervical cancer prevention effort in Malawi

UNC-led team awarded $5.1 million for cervical cancer prevention effort in Malawi

Jennifer Tang, MD, and Lameck Chinula, MMED, both in the department of obstetrics and gynecology at the UNC School of Medicine, are co-principal investigators for this USAID grant to more effectively combat cervical cancer, the leading cause of death among women in Malawi.

UNC-led team awarded $5.1 million for cervical cancer prevention effort in Malawi - Read More…

Muenzer Presents Additional Results from Groundbreaking Genome Editing Clinical Trial

Muenzer Presents Additional Results from Groundbreaking Genome Editing Clinical Trial

Interim results presented by UNC's Joseph Muenzer, MD, PhD, provide preliminary evidence that in vivo genome editing occurred in a clinical trial testing a treatment for Mucopolysaccharidosis Type II (MPS II), also known as Hunter syndrome.

Muenzer Presents Additional Results from Groundbreaking Genome Editing Clinical Trial - Read More…